Emergent BioSolutions Announces CFO Transition and Appointment of Interim CFO

Emergent BioSolutions Inc. announced that Richard Lindahl, the company's Chief Financial Officer, will step down from his role effective December 31, 2026, and will continue as an advisor until his retirement on March 31, 2027. Frank Vargo, Vice President, Treasurer, has been appointed to serve as the Interim Chief Financial Officer starting January 1, 2027.